PO-2241 Understanding cGAS activation: the key to unravelling the full potential of ablative therapies?

Autor: Mekers, V., Looman, M., van den Boogaard, L., Bussink, J., Ansems, M., Adema, G.

Publikováno v: In Radiotherapy and Oncology May 2023 182 Supplement 1:S2015-S2017

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

OC-0594 Head and Neck Squamous Cell Carcinoma derived CAFs alter their phenotype after ionizing radation.

Autor: Ansems, M. (AUTHOR), Mekers, V. (AUTHOR), Beerkens, A. (AUTHOR), Dotinga, M. (AUTHOR), Strepi, K. (AUTHOR), Honings, J. (AUTHOR), Weijs, W. (AUTHOR), Adema, G.J. (AUTHOR), Kaanders, J.H. (AUTHOR), Bussink, J. (AUTHOR)

Publikováno v: Radiotherapy & Oncology. 2022 Supplement 1, Vol. 170, pS519-S520. 2p.

Mechanical HIFU and immune checkpoint inhibition: toward clinical implementation.

Autor: Mekers V; Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, Netherlands., de Visser M; Division of Imaging & Oncology, University Medical Center Utrecht, Utrecht, Netherlands., Suijkerbuijk K; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, Netherlands., Bos C; Division of Imaging & Oncology, University Medical Center Utrecht, Utrecht, Netherlands., Moonen C; Division of Imaging & Oncology, University Medical Center Utrecht, Utrecht, Netherlands.; Focused Ultrasound Foundation, Charlottesville, VA, USA., Deckers R; Division of Imaging & Oncology, University Medical Center Utrecht, Utrecht, Netherlands., Adema G; Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, Netherlands.

Publikováno v: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2024; Vol. 41 (1), pp. 2430333. Date of Electronic Publication: 2024 Nov 20.